LGBT LIFE CENTER

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

STACIE WALLS

Phone

7576400929

Tax Period

2024-07-01 to 2025-06-30

LGBT LIFE CENTER, founded in 1990, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $15.2M in total revenue in fiscal year 2024. Revenue surged 28% from the prior year, signaling strong growth momentum. Expenses of $14.0M left a modest 8% surplus.

Mission

LGBT LIFE CENTER IS A TRUSTED LEADER THAT EMPOWERS THE LGBTQ COMMUNITIES AND ALL PEOPLE AFFECTED BY HIV THROUGH IMPROVING HEALTH AND WELLNESS, STRENGTHENING FAMILIES AND COMMUNITIES, AND PROVIDING TRANSFORMATIVE EDUCATION AND ADVOCACY.

Program Service Accomplishments

Program 1

Expenses: $6,154,701 Revenue: $88,639

SERVICES INCLUDE MEDICAL CASE MANAGEMENT, TRANSPORTATION, PERMANENT SUPPORTIVE HOUSING, RENTAL AND UTILITY ASSISTANCE, HIV TESTING, HIV PREVENTION AND EDUCATION, MEALS PROGRAM, OUTREACH, MEDICATION AND BENEFIT ASSISTANCE, ADHERENCE SUPPORT AND YOUTH SERVICES FOR PERSONS WHO ARE LGBTQ AND PERSONS WITH HIV/AIDS.

Program 2

Expenses: $6,318,308 Revenue: $7,993,509

THE 340B PHARMACY PROGRAM IS A FEDERAL PHARMACY PROGRAM WITHIN THE OFFICE OF PHARMACY AFFAIRS AT HRSA. THE ORGANIZATION IS A "COVERED ENTITY" WITHIN THIS PROGRAM AND THEREFORE ELIGIBLE TO PURCHASE...

THE 340B PHARMACY PROGRAM IS A FEDERAL PHARMACY PROGRAM WITHIN THE OFFICE OF PHARMACY AFFAIRS AT HRSA. THE ORGANIZATION IS A "COVERED ENTITY" WITHIN THIS PROGRAM AND THEREFORE ELIGIBLE TO PURCHASE HIV MEDIATIONS AND STI/PREP MEDICATIONS AT REDUCED PRICES FROM WHOLESALE MANUFACTURERS. THE ORGANIZATION CONTRACTS WITH MULTIPLE CONTRACT PHARMACIES TO DISPENSE MEDICATIONS TO ELIGIBLE CLIENTS PARTICIPATING IN THE PROGRAM. THE 340B PROGRAM SERVES AS A MEDICATION COMPLIANCE PROGRAM FOR MEDICAL CASE MANAGERS TO MONITOR MEDICATION UTILIZATION AND STI TREATMENT FOR ELIGIBLE PATIENTS. ALL PATIENTS ARE EITHER ENROLLED IN MEDICAL CASE MANAGEMENT OR CARE NAVIGATION SERVICES. THE PROGRAM REVENUE IS UTILIZED TO SUPPORT THE INFRASTRUCTURE AND PROGRAMS OF THE ORGANIZATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $7,122,603

Program Service Revenue $8,082,148

Investment Income $9,705

Other Revenue $-51,213

TOTAL REVENUE $15,163,243

Expense Breakdown

Grants Paid $2,206,136

Salaries & Benefits $3,896,867

Fundraising Expenses $84,557

Program Expenses $12,473,009

Other Expenses $7,895,101

TOTAL EXPENSES $13,998,104

Year-over-Year Comparison

	2024	2023	Change
Revenue	$15,163,243	$11,858,781	+0.3%
Expenses	$13,998,104	$10,091,131	+0.4%
Net Income	$1,165,139	$1,767,650	-0.3%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

651

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$198,167

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LISA STAFFORD	CHAIR	1.00	Officer Director	$0	$0	$0
EDWARD LAWRENCE	TREASURER	1.00	Officer Director	$0	$0	$0
VIRGINIA PENNY SANCHEZ	DIRECTOR	1.00	Director	$0	$0	$0
KEN NELMS	DIRECTOR	1.00	Director	$0	$0	$0
QUAN MCLAURIN	SECRETARY	1.00	Officer Director	$0	$0	$0
ANDREW MOSKOWICZ	VICE CHAIR	1.00	Officer Director	$0	$0	$0
JOHN HIERSPIEL	DIRECTOR	1.00	Director	$0	$0	$0
JUSTIN FULTON	DIRECTOR	1.00	Director	$0	$0	$0
LUIS ESTRADA	DIRECTOR	1.00	Director	$0	$0	$0
STACIE WALLS	CHIEF EXECUTIVE OFFICER	40.00	Officer	$195,534	$2,633	$198,167
CHRISTOPHER P REYBROUCK	SENIOR DIRECTOR OF STRATEGY AND OPERATIONS	40.00	Highest	$106,830	$2,531	$109,361
BRITNEY BREITSCH	DIRECTOR OF FINANCE	40.00	Highest	$110,000	$3,600	$113,600
CORY MOHR	DIRECTOR OF COMMUNICATIONS	40.00	Highest	$109,821	$102	$109,923

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$15,163,243	$13,998,104	$7,917,578	$1,165,139
2024	$11,858,781	$10,091,131	$6,762,143	$1,767,650
2023	$10,364,387	$10,756,738	$5,822,081	$-392,351
2022	$15,195,335	$14,886,285	$5,646,401	$309,050
2021	$11,398,253	$10,166,678	$4,644,731	$1,231,575
2020	$7,863,854	$8,161,793	$3,283,905	$-297,939
2019	$8,375,786	$8,612,519	$3,030,865	$-236,733
2018	$8,213,882	$8,101,741	$3,147,746	$112,141